Nanexa
Uppsala, Sweden· Est. 2009
Redefining Injectables.One Layer at a Time. Where NanoengineeringMeets Drug Delivery Nanexa’s PharmaShell® technology is transforming the face of long-acting ’super generic’ drugs with its proprietary suite of Atomic Layer Deposition (ALD) technologies.Read more
Private Company
Total funding raised: $8.7M
About
Redefining Injectables.One Layer at a Time. Where NanoengineeringMeets Drug Delivery Nanexa’s PharmaShell® technology is transforming the face of long-acting ’super generic’ drugs with its proprietary suite of Atomic Layer Deposition (ALD) technologies.Read more
Drug Delivery
Funding History
2Total raised:$8.7M
Grant$500KMar 15, 2022
IPO$8.2MJun 15, 2021